[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343753-105":59,"doc-detail-343753-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","differences-in-the-pathological-transcriptomic-and-prognostic-implications-of-lymphoid-structures-between-primary-and-metastatic-cutaneous-melanomas","Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas","","Background explores whether immature precursor lymphoid structures, termed lymphoid aggregates (LA), and tertiary lymphoid structures (TLS) differ in prevalence and clinical impact across primary versus metastatic cutaneous melanoma. Methods analyze histological samples using H&E staining, multiplex immunofluorescence, and transcriptomic analyses, with Cox proportional hazards regression to test prognostic associations. Results evaluate 278 samples and relate LA/TLS presence to tumor microenvironment heterogeneity and survival outcomes. Conclusion links LA-rich immune niches with improved overall survival and favorable nodal status in melanoma patients.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/differences-in-the-pathological-transcriptomic-and-prognostic-implications-of-lymphoid-structures-between-primary-and-metastatic-cutaneous-melanomas/343753/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/differences-in-the-pathological-transcriptomic-and-prognostic-implications-of-lymphoid-structures-between-primary-and-metastatic-cutaneous-melanomas/343753.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the study address about lymphoid structures in melanoma?","Question",{"text":113,"@type":114},"It examines how lymphoid aggregates (LA) and tertiary lymphoid structures (TLS) differ between primary and metastatic cutaneous melanomas, including their prevalence and prognostic value.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were LA and TLS identified in the analyzed samples?",{"text":118,"@type":114},"The study used H&E staining, multiplex immunofluorescence, and transcriptomic analyses on melanoma specimens and digital slides to detect LA/TLS and characterize them.",{"name":120,"@type":111,"acceptedAnswer":121},"What prognostic associations were reported for the presence of LA or TLS?",{"text":122,"@type":114},"Presence of LA was associated with improved overall survival, and LA was linked to tumor-free regional lymph node status; TLS was observed in a smaller fraction of evaluated melanoma specimens.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},343753,1790621582,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Open access Original research  \n Differences in the pathological,  \ntranscriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas  \nLilit Karapetyan  ,1 Aofei Li,2,3 Danielle Vargas De Stefano,4,5  \nHassan M Abushukair  ,6,7,8 Ayah N Al-Bzour  ,6 Andrew Knight,9  \nCaroline Layding,3,10 Hong Wang,10 Jin Xu,11,12 Jiqiang Yao,11,12 Xiaofei Song,11,12 Marion Joy,5 Jonathan Nguyen,13 Carlos Moran-Segura  ,13 Sabrina Bruno,14 Cindy Sander,15 Jane Messina,16 James J Mule  ,11 Walter J Storkus  ,17,18 John M Kirkwood19  \nTo cite: Karapetyan L, Li A, Vargas De Stefano D, et al. Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas. Journal for ImmunoTherapy of Cancer 2024;12:e009231 . doi:10 . 1136/ jitc-2024-009231  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2024-009231](jitc-2024-009231)) .  \nJJM, WJS and JMK are joint senior authors.  \nAccepted 13 October 2024  \n© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Lilit Karapetyan;  \n[lilit.karapetyan@moffitt.org](lilit.karapetyan@moffitt.org)  \nABSTRACT  \nBackground While the prognostic role of tertiary lymphoid structures (TLS) has been well studied in solid cancers, the prevalence and impact of immature precursor lymphoid structures known as lymphoid aggregates (LA) remain unresolved in relation to the disease process. In this study, we examined characteristics and the prognostic utility of LA and TLS status in histological samples from patients with melanoma.  \nMethods We assessed The Cancer Genomic Atlasskin cutaneous melanoma digital slides and melanoma specimens from the University of Pittsburgh for the presence of LA and TLS using H&E staining, multiplex immunofluorescence (mIF) and transcriptomic analyses. Cox proportional hazard regression models were used to assess the prognostic value associated with the presence of lymphoid structures in melanomas.  \nResults A total of 278 evaluable samples were analyzed and split into primary melanomas in skin (N=195) and metastatic melanomas involving skin/ subcutaneous/soft tissue sites (N=83) . 72% of tumor specimens contained histologically defined LA located in peritumoral (34%), intratumoral (5 . 6%) or stromal  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n⇒ Tertiary lymphoid structures (TLS) are associated with improved prognostic outcome in solid cancersin general.  \nWHAT THIS STUDY ADDS  \n⇒ This study reports the first assessment of heterogeneous presence of lymphoid structures in primary and metastatic melanomas involving skin/subcutaneous/soft tissues. These lymphoid structures exhibit diversity in their morphologic appearance on H&E assessment, and varied cellular composition based on multiplex immunofluorescence analyses, but consistent expression of the 12-chemokine gene expression score. Notably, these features are negatively correlated with pigmentation/neural network gene signatures. Furthermore, melanomas tend to present with predominantly immature lymphoid structures in mixed locations, which appear related to improved overall survival and the absence of lymph node involvement in patients with primary melanomas.  \n(6.1%) locations, with the remaining samples (54.3%) (p\u003C0 . 001), and samples without LA/TLS were enriched exhibiting LA in multiple locations. In contrast to LA with pigmentation/neural network gene signatures. which tended to form more commonly in primary The presence of LA was significantly associated with  \nmelanoma samples, TLS with germinal centers tumor-free regional lymph node status (p=0 . 002) . In  \npredominantly formed in peritumoral (45.2%) or mu","cbCaikMi4xJKvlOZ","https://ap.wps.com/l/cbCaikMi4xJKvlOZ","pdf",3047478,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# What is already known on this topic\n# What this study adds\n# How this study might affect research, practice or policy","[{\"question\":\"What question does the study address about lymphoid structures in melanoma?\",\"answer\":\"It examines how lymphoid aggregates (LA) and tertiary lymphoid structures (TLS) differ between primary and metastatic cutaneous melanomas, including their prevalence and prognostic value.\"},{\"question\":\"How were LA and TLS identified in the analyzed samples?\",\"answer\":\"The study used H\\u0026E staining, multiplex immunofluorescence, and transcriptomic analyses on melanoma specimens and digital slides to detect LA/TLS and characterize them.\"},{\"question\":\"What prognostic associations were reported for the presence of LA or TLS?\",\"answer\":\"Presence of LA was associated with improved overall survival, and LA was linked to tumor-free regional lymph node status; TLS was observed in a smaller fraction of evaluated melanoma specimens.\"}]","Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas | PDF",1790052024,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/016f39ac2e35c2bef3b0106f7ab98c4d.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ba539826e34edb9eed716aeaabb84b0.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86cfad1b4fcd0a1c0d725125c5ea9220.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37234b8c6dc1f77fd8349b9861a473d7.webp",980,1306]